Sam Williams is IP Group’s Investor Director. Sam has 20 years of experience in the biotechnology industry, both as a top-ranked equity analyst in the City and, subsequently, as an entrepreneur and Chief Executive.
Sam is Executive Chairman of Istesso Limited, a Non-Executive Director of Diurnal Group plc, and Managing Partner, Life Sciences, at IP Group. He holds a Ph.D. in molecular biology from Cambridge and a degree in Biology from Oxford.